Adipose-derived stromal/stem cells and extracellular vesicles for cancer therapy

References

• Uccelli A, Moretta L, Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol. 2008;8(9):726–736.
   PubMed Web of Science ®Google Scholar
• Galipeau J, Sensébé L. Mesenchymal stromal cells: clinical challenges and therapeutic opportunities. Cell Stem Cell. 2018;22(6):824–833.
   PubMed Web of Science ®Google Scholar
• Mitchell JB, McIntosh K, Zvonic S, et al. Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers. Stem Cells. 2006;24(2):376–385.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8:315–317.
   PubMed Web of Science ®Google Scholar
• Wankhade UD, Shen M, Kolhe R, et al. Advances in adipose-derived stem cells isolation, characterization, and application in regenerative tissue engineering. Stem Cells Int. 2016;2016:3206807.
   PubMed Web of Science ®Google Scholar
• Pittenger MF, Discher DE, Péault BM, et al. Mesenchymal stem cell perspective: cell biology to clinical progress. NPJ Regen Med. 2019;4:22.
   PubMed Web of Science ®Google Scholar
• Si Z, Wang X, Sun C, et al. Adipose-derived stem cells: sources, potency, and implications for regenerative therapies. Biomed Pharmacother. 2019;114:108765.
   PubMed Web of Science ®Google Scholar
• Rajabzadeh N, Fathi E, Farahzadi R. Stem cell-based regenerative medicine. Stem Cell Investig. 2019;6:19.
   PubMedGoogle Scholar
• Dubey NK, Mishra VK, Dubey R, et al. Revisiting the advances in isolation, characterization and secretome of adipose-derived stromal/stem cells. Int J Mol Sci. 2018;19(8):2200.
   PubMed Web of Science ®Google Scholar
• Frese L, Dijkman PE, Hoerstrup SP. Adipose tissue-derived stem cells in regenerative medicine. Transfus Med Hemother. 2016;43(4):268–274.
   PubMed Web of Science ®Google Scholar
• Fu Y, Karbaat L, Wu L, et al. Trophic effects of mesenchymal stem cells in tissue regeneration. Tissue Eng Part B Rev. 2017;23(6):515–528.
   PubMed Web of Science ®Google Scholar
• Harrell CR, Jankovic MG, Fellabaum C, et al. Molecular mechanisms responsible for anti-inflammatory and immunosuppressive effects of mesenchymal stem cell-derived factors. Adv Exp Med Biol. 2019;1084:187–206.
   PubMed Web of Science ®Google Scholar
• [ cited 2021 Feb 25]. Available from: www.clinicaltrials.gov
   Google Scholar
• Shukla L, Yuan Y, Shayan R, et al. Fat therapeutics: the clinical capacity of adipose-derived stem cells and exosomes for human disease and tissue regeneration. Front Pharmacol. 2020;11:158.
   PubMed Web of Science ®Google Scholar
• Zhang B, Yin Y, Lai RC, et al. Mesenchymal stem cells secrete immunologically active exosomes. Stem Cells Dev. 2013;23(11):1233–1244.
   Web of Science ®Google Scholar
• Phinney DG, Prockop DJ. Concise review: mesenchymal stem/multipotent stromal cells: the state of transdifferentiation and modes of tissue repair--current views. Stem Cells. 2007;25(11):2896–2902.
   PubMed Web of Science ®Google Scholar
• Volarevic V, Markovic BS, Gazdic M, et al. Ethical and safety issues of stem cell-based therapy. Int J Med Sci. 2018;15(1):36–45.
   PubMed Web of Science ®Google Scholar
• Berglund AK, Fortier LA, Antczak DF, et al. Immunoprivileged no more: measuring the immunogenicity of allogeneic adult mesenchymal stem cells. Stem Cell Res Ther. 2017;8(1):288.
   PubMed Web of Science ®Google Scholar
• Shukla L, Morrison WA, Shayan R. Adipose-derived stem cells in radiotherapy injury: a new frontier. Front Surg. 2015;2:1.
   PubMed Web of Science ®Google Scholar
• Teufelsbauer M, Rath B, Moser D, et al. Interaction of adipose-derived stromal cells with breast cancer cell lines. Plast Reconstr Surg. 2019;144(2):207e–217e.
   PubMed Web of Science ®Google Scholar
• Varderidou-Minasian S, Lorenowicz MJ. Mesenchymal stromal/stem cell-derived extracellular vesicles in tissue repair: challenges and opportunities. Theranostics. 2020;10(13):5979–5997.
   PubMed Web of Science ®Google Scholar
• Zimmerlin L, Donnenberg VS, Pfeifer ME, et al. Stromal vascular progenitors in adult human adipose tissue. Cytometry A. 2010;77(1):22–30.
   PubMed Web of Science ®Google Scholar
• Marigo I, Dazzi F. The immunomodulatory properties of mesenchymal stem cells. Semin Immunopathol. 2011;33(6):593–602.
   PubMed Web of Science ®Google Scholar
• Vu B, Phan N, Pham P. Mesenchymal stem cells: vector for targeted cancer therapy. Prog Stem Cell. 2016;3(1):73–86.
   Google Scholar
• Quan M, Kuang S. Exosomal secretion of adipose tissue during various physiological states. Pharm Res. 2020;37(11):221.
   PubMed Web of Science ®Google Scholar
• Kamal MM, Kassem DH. Therapeutic potential of wharton’s jelly mesenchymal stem cells for diabetes: achievements and challenges. Front Cell Dev Biol. 2020;8:16.
   PubMed Web of Science ®Google Scholar
• Goodwin HS, Bicknese AR, Chien SN, et al. Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biol Blood Marrow Transplant. 2001;7(11):581–588.
   PubMed Web of Science ®Google Scholar
• Chang YJ, Shih DT, Tseng CP, et al. Disparate mesenchyme-lineage tendencies in mesenchymal stem cells from human bone marrow and umbilical cord blood. Stem Cells. 2006;24(3):679–685.
   PubMed Web of Science ®Google Scholar
• Bieback K, Kern S, Kluter H, et al. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells. 2004;22(4):625–634.
   PubMed Web of Science ®Google Scholar
• Arutyunyan I, Elchaninov A, Makarov A, et al. Umbilical cord as prospective source for mesenchymal stem cell-based therapy. Stem Cells Int. 2016;2016:6901286.
   PubMed Web of Science ®Google Scholar
• Shetty P, Cooper K, Viswanathan C. Comparison of proliferative and multilineage differentiation potentials of cord matrix, cord blood, and bone marrow mesenchymal stem cells. Asian J Transfus Sci. 2010;4(1):14–24.
   PubMedGoogle Scholar
• Fong C, Chak L, Biswas A, et al. Human Wharton’s jelly stem cells have unique transcriptome profiles compared to human embryonic stem cells and other mesenchymal stem cells. Stem Cell Rev Rep. 2011;7(1):1–16.
   PubMed Web of Science ®Google Scholar
• Mazini L, Rochette L, Amine M, et al. Regenerative capacity of adipose derived stem cells (adscs), comparison with mesenchymal stem cells (MSCs). Int J Mol Sci. 2019;20:2530.
   Web of Science ®Google Scholar
• de Girolamo L, Lucarelli E, Alessandri G, et al. Italian Mesenchymal Stem Cell Group. Mesenchymal stem/stromal cells: a new “cells as drugs” paradigm. Efficacy and critical aspects in cell therapy. Curr Pharm Des. 2013;19(13):2459–2473.
   PubMed Web of Science ®Google Scholar
• Mehranfar S, Abdi Rad I, Mostafav E, et al. The use of stromal vascular fraction (SVF), platelet-rich plasma (PRP) and stem cells in the treatment of osteoarthritis: an overview of clinical trials. Artif Cells Nanomed Biotechnol. 2019;47(1):882–890.
   PubMed Web of Science ®Google Scholar
• Doucet C, Ernou I, Zhang YZ, et al. Platelet lysates promote mesenchymal stem cell expansion: a safety substitute for animal serum in cell-based therapy applications. J Cell Physiol. 2005;205(2):228–236.
   PubMed Web of Science ®Google Scholar
• Lechanteur C, Briquet A, Giet O, et al. Clinical scale expansion of mesenchymal stromal cells: a large banking experience. J Transl Med. 2016;14(1):145.
   PubMed Web of Science ®Google Scholar
• Hanley PJ, Mei Z, Durett AG, et al. Efficient manufacturing of therapeutic mesenchymal stromal cells with the use of the Quantum Cell Expansion System. Cytotherapy. 2014;16:1048–1058.
   PubMed Web of Science ®Google Scholar
• Honczarenko M, Le Y, Swierkowski M, et al. Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem Cells. 2006;24:1030–1041.
   PubMed Web of Science ®Google Scholar
• Yoshimura K, Asano Y, Aoi N, et al. Progenitor-enriched adipose tissue transplantation as rescue for breast implant complications. Breast J. 2010;16(2):169–175.
   PubMed Web of Science ®Google Scholar
• Eto H, Suga H, Matsumoto D, et al. Characterization of structure and cellular components of aspirated and excised adipose tissue. Plast Reconstr Surg. 2009;124(4):1087–1097.
   PubMed Web of Science ®Google Scholar
• Gurtner GC, Werner S, Barrandon Y, et al. Wound repair and regeneration. Nature. 2008;453(7193):314–321.
   PubMed Web of Science ®Google Scholar
• Spiekman M, van Dongen JA, Willemsen JC, et al. The power of fat and its adipose-derived stromal cells: emerging concepts for fibrotic scar treatment. J Tissue Eng Regen Med. 2017;11(11):3220–3235.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhang B, Liao B, et al. Platelet-rich plasma in combination with adipose-derived stem cells promotes skin wound healing through activating Rho GTPase-mediated signaling pathway. Am J Transl Res. 2019;11(7):4100–4112.
   PubMed Web of Science ®Google Scholar
• Lanao JM, Gutiérrez-Millán C, Colino CI. Cell-based drug delivery platforms. Pharmaceutics. 2020;13:1.
   Web of Science ®Google Scholar
• Pessina A, Bonomi A, Coccè V, et al. Mesenchymal stromal cells primed with paclitaxel provide a new approach for cancer therapy. PLoS One. 2011;6(12):e28321.
   PubMed Web of Science ®Google Scholar
• Pascucci L, Cocce V, Bonomi A, et al. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery. J Control Release. 2014;192:262–270.
   PubMed Web of Science ®Google Scholar
• Cocce V, Farronato D, Brini AT, et al. Drug loaded gingival mesenchymal stromal cells (GinPa-MSCs) inhibit in vitro proliferation of oral squamous cell carcinoma. Sci Rep. 2017;7:9376.
   PubMed Web of Science ®Google Scholar
• Bonomi A, Coccè V, Cavicchini L, et al. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity. Int J Immunopathol Pharmacol. 2013;26(1Suppl):33–41.
   PubMed Web of Science ®Google Scholar
• Brini AT, Cocce V, Ferreira LM, et al. Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel. Expert Opin Drug Deliv. 2016;13(6):789–798.
   PubMed Web of Science ®Google Scholar
• Nicolay NH, Lopez Perez R, Ruhle A, et al. Mesenchymal stem cells maintain their defining stem cell characteristics after treatment with cisplatin. Sci Rep. 2016;6:20035.
   PubMed Web of Science ®Google Scholar
• Gilazieva ZE, Tazetdinova LG, Arkhipova SS, et al. Effect of cisplatin on ultrastructure and viability of adipose-derived mesenchymal stem cells. BioNanoScience. 2016;6:534–539.
   Web of Science ®Google Scholar
• Li L, Guan Y, Liu H, et al. Silica nanorattledoxorubicin-anchored mesenchymal stem cells for tumor-tropic therapy. ACS Nano. 2011;5(9):7462–7470.
   PubMed Web of Science ®Google Scholar
• Kamdje AHN, Etet PFS, Simo RT, et al. Emerging data supporting stromal cell therapeutic potential in cancer: reprogramming stromal cells of the tumor microenvironment for anti-cancer effects. Cancer Biol Med. 2020;17(4):828–841.
   PubMed Web of Science ®Google Scholar
• Atiya H, Frisbie L, Pressimone C, et al. Mesenchymal stem cells in the tumor microenvironment. Adv Exp Med Biol. 2020;1234:31–42.
   PubMed Web of Science ®Google Scholar
• Shah K. Mesenchymal stem cells engineered for cancer therapy. Adv Drug Deliv Rev. 2012;64(8):739–748.
   PubMed Web of Science ®Google Scholar
• Prindull G, Ben-Ishay Z, Ebell W, et al. CFU-F circulating in cord blood. Blut. 1987;54(6):351–359.
   PubMedGoogle Scholar
• Sushilkumar R, Shabari S, Chandra V. Potential of mesenchymal stem cell-based application in cancer. Int J Hematol Oncol Stem Cell Res. 2015;9(2):95–103.
   PubMedGoogle Scholar
• Kucerova L, Skolekova S, Matuskova M, et al. Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells. BMC Cancer. 2013;9:13: 535.
   Google Scholar
• Otsu K, Das S, Houser SD, et al. Concentration-dependent inhibition of angiogenesis by mesenchymal stem cells. Blood. 2009;113(18):4197–4205.
   PubMed Web of Science ®Google Scholar
• Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med. 1986;315(26):1650–1659.
   PubMed Web of Science ®Google Scholar
• Son BR, Marquez-Curtis LA, Kucia M, et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by stromal-derived factor-1-CXCR4 and hepatocyte growth factor-c-met axes and involves matrix metalloproteinases. Stem Cells. 2006;24(5):1254–1264.
   PubMed Web of Science ®Google Scholar
• Ramdasi S, Sarang S, Viswanathan C. Potential of mesenchymal stem cell based application in cancer. Int J Hematol Oncol Stem Cell Res. 2015;9(2):95–103.
   PubMedGoogle Scholar
• Chulpanova DS, Kitaeva KV, Tazetdinova LG, et al. Application of mesenchymal stem cells for therapeutic agent delivery in anti-tumor treatment. Front Pharmacol. 2018;9:259.
   PubMed Web of Science ®Google Scholar
• Borghese C, Casagrande N, Corona G, et al. Adipose-derived stem cells primed with paclitaxel inhibit ovarian cancer spheroid growth and overcome paclitaxel resistance. Pharmaceutics. 2020;12(5):401.
   Web of Science ®Google Scholar
• Mirzaei H, Salehi H, Oskuee RK, et al. The therapeutic potential of human adipose-derived mesenchymal stem cells producing CXCL10 in a mouse melanoma lung metastasis model. Cancer Lett. 2018;419:30–39.
   PubMed Web of Science ®Google Scholar
• Cocce V, Balducci L, Falchetti ML, et al. Fluorescent immortalized human adipose derived stromal cells (hASCs-TS/GFP+) for studying cell drug delivery mediated by microvesicles. Anticancer Agents Med Chem. 2017;17(11):1578–1585.
   PubMed Web of Science ®Google Scholar
• Cheng S, Nethi SK, Rathi S, et al. Engineered mesenchymal stem cells for targeting solid tumors: therapeutic potential beyond regenerative therapy. J Pharmacol Exp Ther. 2019;370(2):231–241.
   PubMed Web of Science ®Google Scholar
• Melzer C, Rehn V, Yang Y, et al. Taxol-loaded MSC-derived exosomes provide a therapeutic vehicle to target metastatic breast cancer and other carcinoma cells. Cancers (Basel). 2019;11(6):798.
   PubMed Web of Science ®Google Scholar
• Crivelli B, Chlapanidas T, Perteghella S, et al. Mesenchymal stem/stromal cell extracellular vesicles: from active principle to next generation drug delivery system. J Control Release. 2017;262:104–117.
   PubMed Web of Science ®Google Scholar
• Wiklander OPB, Brennan MA, Lotvall J, et al. Advances in therapeutic applications of extracellular vesicles. Sci Transl Med. 2019;11(492):eaav8521.
   PubMed Web of Science ®Google Scholar
• Melling GE, Carollo E, Conlon R, et al. The challenges and possibilities of extracellular vesicles as therapeutic vehicles. Eur J Pharm Biopharm. 2019;144:50–56.
   PubMed Web of Science ®Google Scholar
• Cai Y, Li J, Jia C, et al. Therapeutic applications of adipose cell-free derivatives: a review. Stem Cell Res Ther. 2020;11(1):312.
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang T, Zhang L, et al. Combination of lyophilized adipose-derived stem cell concentrated conditioned medium and polysaccharide hydrogel in the inhibition of hypertrophic scarring. Stem Cell Res Ther. 2021;12(1):23.
   PubMed Web of Science ®Google Scholar
• Choi EW, Seo MK, Woo EY, et al. Exosomes from human adipose-derived stem cells promote proliferation and migration of skin fibroblasts. Exp Dermatol. 2018;27(10):1170–1172.
   PubMed Web of Science ®Google Scholar
• Squillaro T, Peluso G, Galderisi U. Clinical trials with mesenchymal stem cells: an update. Cell Transplant. 2016;25(5):829–848.
   PubMed Web of Science ®Google Scholar
• Xu R, Rai A, Chen M, et al. Extracellular vesicles in cancer - implications for future improvements in cancer care. Nat Rev Clin Oncol. 2018;15(10):617–638.
   PubMed Web of Science ®Google Scholar
• Qiu H, Liu S, Wu K, et al. Prospective application of exosomes derived from adipose-derived stem cells in skin wound healing: a review. J Cosmet Dermatol. 2020;19(3):574–581.
   PubMed Web of Science ®Google Scholar
• Thery C, Witwer KW, Aikawa E, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the international society for extracellular vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles. 2018;7(1):1535750.
   PubMed Web of Science ®Google Scholar
• Tkach M, Théry C. Communication by extracellular vesicles: where we are and where we need to go. Cell. 2016;164(6):1226–1232.
   PubMed Web of Science ®Google Scholar
• de Jong B, Barros ER, Hoenderop JGJ, et al. Recent advances in extracellular vesicles as drug delivery systems and their potential in precision medicine. Pharmaceutics. 2020;12(11):1006.
   Web of Science ®Google Scholar
• Wolfram J, Ferrari M. Clinical cancer nanomedicine. Nano Today. 2019;25:85–98.
   PubMed Web of Science ®Google Scholar
• Yamamoto T, Kosaka N, Ochiya T. Latest advances in extracellular vesicles: from bench to bedside. Sci Technol Adv Mater. 2019;20(1):746–757.
   PubMed Web of Science ®Google Scholar
• Rai A, Greening DW, Chen M, et al. Exosomes derived from human primary and metastatic colorectal cancer cells contribute to functional heterogeneity of activated fibroblasts by reprogramming their proteome. Proteomics. 2019;19(8):e1800148.
   PubMed Web of Science ®Google Scholar
• Elsharkasy OM, Nordin JZ, Hagey DW, et al. Extracellular vesicles as drug delivery systems: why and how? Adv Drug Deliv Rev. 2020;159:332–343.
   PubMed Web of Science ®Google Scholar
• van Niel G, D’Angelo G, Raposo G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2018;19(4):213–228.
   PubMed Web of Science ®Google Scholar
• Ferreira ADF, Gomes DA. Stem cell extracellular vesicles in skin repair. Bioengineering (Basel). 2018;6(1):4.
   PubMedGoogle Scholar
• Antonyak MA, Cerione RA. Natl Acad Sci USA. Emerging picture of the distinct traits and functions of microvesicles and exosomes. Proc Natl Acad Sci USA. 2015;112(12):3589–3590.
   PubMed Web of Science ®Google Scholar
• Thomou T, Mori MA, Dreyfuss JM, et al. Adipose-derived circulating miRNAs regulate gene expression in other tissues. Nature. 2017;542(7642):450–455.
   PubMed Web of Science ®Google Scholar
• Tomuleasa C, Braicu C, Irimie A, et al. Nanopharmacology in translational hematology and oncology. Int J Nanomedicine. 2014;9:3465–3479.
   PubMed Web of Science ®Google Scholar
• Munteanu R, Onaciu A, Moldovan C, et al. Adipocyte-based cell therapy in oncology: the role of cancer-associated adipocytes and their reinterpretation as delivery platforms. Pharmaceutics. 2020;12(5):402.
   Web of Science ®Google Scholar
• Yim N, Ryu SW, Choi K, et al. Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module. Nat Commun. 2016;22(7):12277.
   Web of Science ®Google Scholar
• Rohde E, Pachler K, Gimona M. Manufacturing and characterization of extracellular vesicles from umbilical cord-derived mesenchymal stromal cells for clinical testing. Cytotherapy. 2019;21(6):581–592.
   PubMed Web of Science ®Google Scholar
• Brossa A, Fonsato V, Grange C, et al. Extracellular vesicles from human liver stem cells inhibit renal cancer stem cell-derived tumor growth in vitro and in vivo. Int J Cancer. 2020;147(6):1694–1706.
   PubMed Web of Science ®Google Scholar
• Yong T, Zhang X, Bie N, et al. Tumor exosome-based nanoparticles are efficient drug carriers for chemotherapy. Nat Commun. 2019;10(1):3838.
   PubMed Web of Science ®Google Scholar
• Scholl JN, de Fraga Dias A, Pizzato PR, et al. Characterization and antiproliferative activity of glioma-derived extracellular vesicles. Nanomed (Lond). 2020;15(10):1001–1018.
   PubMed Web of Science ®Google Scholar
• Wiklander OP, Nordin JZ, O’Loughlin A, et al. Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting. J Extracell Vesicles. 2015;4:26316.
   PubMed Web of Science ®Google Scholar
• Yang -X-X, Sun C, Wang L, et al. New insight into isolation, identification techniques and medical applications of exosomes. J Control Release. 2019;308:119–129.
   PubMed Web of Science ®Google Scholar
• Harrell CR, Fellabaum C, Jovicic N, et al. Molecular mechanisms responsible for therapeutic potential of mesenchymal stem cell-derived secretome. Cells. 2019;8(5):467.
   PubMed Web of Science ®Google Scholar
• Harrell CR, Jovicic N, Djonov V, et al. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells. 2019;8(12):1605.
   PubMed Web of Science ®Google Scholar
• Phinney DG, Pittenger MF. Concise review: MSC-derived exosomes for cell-free therapy. Stem Cells. 2017;35(4):851–858.
   PubMed Web of Science ®Google Scholar
• Qiu G, Zheng G, Ge M, et al. Mesenchymal stem cell-derived extracellular vesicles affect disease outcomes via transfer of microRNAs. Stem Cell Res Ther. 2018;9(1):320.
   PubMed Web of Science ®Google Scholar
• Harrell CR, Jovicic N, Djonov V, et al. Therapeutic use of mesenchymal stem cell-derived exosomes: from basic science to clinics. Pharmaceutics. 2020;12(5):474.
   Web of Science ®Google Scholar
• Mendt M, Rezvani K, Shpall E. Mesenchymal stem cell-derived exosomes for clinical use. Bone Marrow Transplant. 2019;54(Suppl 2):789–792.
   PubMed Web of Science ®Google Scholar
• Leibacher J, Henschler R. Biodistribution, migration and homing of systemically applied mesenchymal stem/stromal cells. Stem Cell Res Ther. 2016;7:7.
   PubMed Web of Science ®Google Scholar
• Zhuang WZ, Lin YH, Su LJ, et al. Mesenchymal stem/stromal cell-based therapy: mechanism, systemic safety and biodistribution for precision clinical applications. J Biomed Sci. 2021;28(1):28.
   PubMed Web of Science ®Google Scholar
• Geiger A, Walker A, Nissen E. Human fibrocyte-derived exosomes accelerate wound healing in genetically diabetic mice. Biochem Biophys Res Commun. 2015;467(2):303–309.
   PubMed Web of Science ®Google Scholar
• Zhang J, Guan J, Niu X, et al. Exosomes released from human induced pluripotent stem cells-derived MSCs facilitate cutaneous wound healing by promoting collagen synthesis and angiogenesis. J Transl Med. 2015;13:49.
   PubMed Web of Science ®Google Scholar
• Wang L, Hu L, Zhou X, et al. Exosomes secreted by human adipose mesenchymal stem cells promote scarless cutaneous repair by regulating extracellular matrix remodelling. Sci Rep. 2017;7(1):13321.
   PubMed Web of Science ®Google Scholar
• Ren S, Chen J, Duscher D, et al. Microvesicles from human adipose stem cells promote wound healing by optimizing cellular functions via AKT and ERK signaling pathways. Stem Cell Res Ther. 2019;10(1):47.
   PubMed Web of Science ®Google Scholar
• Lopatina T, Bruno S, Tetta C, et al. Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential. Cell Commun Signal. 2014;12:26.
   PubMed Web of Science ®Google Scholar
• Lin R, Wang S, Zhao RC. Exosomes from human adipose-derived mesenchymal stem cells promote migration through Wnt signaling pathway in a breast cancer cell model. Mol Cell Biochem. 2013;383(1–2):13–20.
   PubMed Web of Science ®Google Scholar
• Takahara K, Ii M, Inamoto T, et al. microRNA-145 mediates the inhibitory effect of Adipose tissue-derived stromal cells on prostate cancer. Stem Cells Dev. 2016;25(17):1290–1298.
   PubMed Web of Science ®Google Scholar
• Pariset E, Agache V, Millet A. Extracellular vesicles: isolation methods. Adv Biosyst. 2017;1(5):e1700040.
   PubMed Web of Science ®Google Scholar
• Konoshenko MY, Lekchnov EA, Vlassov AV, et al. Isolation of extracellular vesicles: general methodologies and latest trends. Biomed Res Int. 2018;2018:8545347.
   PubMed Web of Science ®Google Scholar
• Gobin J, Muradia G, Mehic J, et al. Hollow-fiber bioreactor production of extracellular vesicles from human bone marrow mesenchymal stromal cells yields nanovesicles that mirrors the immuno-modulatory antigenic signature of the producer cell. Stem Cell Res Ther. 2021;12(1):127.
   PubMed Web of Science ®Google Scholar
• Kordelas L, Rebmann V, Ludwig AK, et al. MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus host disease. Leukemia. 2014;28(4):970–973.
   PubMed Web of Science ®Google Scholar
• Andaloussi SEL, Mager I, Breakefield XO, et al. Extracellular vesicles: biology and emerging therapeutic opportunities. Nat Rev Drug Discov. 2013;12(5):347–357.
   PubMed Web of Science ®Google Scholar
• Pokharel D, Wijesinghe P, Oenarto V, et al. Deciphering cell-to-cell communication in acquisition of cancer traits: extracellular membrane vesicles are regulators of tissue biomechanics. OMICS. 2016;20(8):462–469.
   PubMed Web of Science ®Google Scholar
• Bliss SA, Sinha G, Sandiford OA, et al. Mesenchymal stem cell-derived exosomes stimulate cycling quiescence and early breast cancer dormancy in bone marrow. Cancer Res. 2016;76(19):5832–5844.
   PubMed Web of Science ®Google Scholar
• Del Fattore A, Luciano R, Saracino R, et al. Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells. Expert Opin Biol Ther. 2015;15(4):495–504.
   PubMed Web of Science ®Google Scholar
• Granneman JG. Delivery of DNA into adipocytes within adipose tissue. Adv Struct Saf Stud. 2008;423:191–195.
   Google Scholar
• Tsai WC, Hsu SD, Hsu CS, et al. MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest. 2012;122(8):2884–2897.
   PubMed Web of Science ®Google Scholar
• Nakao K, Miyaaki H, Ichikawa T. Antitumor function of microRNA-122 against hepatocellular carcinoma. J Gastroenterol. 2014;49(4):589–593.
   PubMed Web of Science ®Google Scholar
• Lou G, Song X, Yang F, et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma. J Hematol Oncol. 2015;8:122.
   PubMed Web of Science ®Google Scholar
• O’Brien KP, Khan S, Gilligan KE, et al. Employing mesenchymal stem cells to support tumor-targeted delivery of extracellular vesicle (EV)-encapsulated microRNA-379. Oncogene. 2018;37(16):2137–2149.
   PubMed Web of Science ®Google Scholar
• Khan S, Brougham CL, Ryan J, et al. miR-379 regulates cyclin B1 expression and is decreased in breast cancer. PLoS One. 2013;8(7):e68753.
   PubMed Web of Science ®Google Scholar
• Mills J, Capece M, Cocucci E, et al. Cancer-derived extracellular vesicle-associated micrornas in intercellular communication: one cell’s trash is another cell’s treasure. Int J Mol Sci. 2019;20(24):6109.
   Web of Science ®Google Scholar
• Robb KP, Fitzgerald JC, Barry F, et al. Mesenchymal stromal cell therapy: progress in manufacturing and assessments of potency. Cytotherapy. 2019;21(3):289–306.
   PubMed Web of Science ®Google Scholar
• Jossen V, van den Bos C, Eibl R, et al. Manufacturing human mesenchymal stem cells at clinical scale: process and regulatory challenges. Appl Microbiol Biotechnol. 2018;102(9):3981–3994.
   PubMed Web of Science ®Google Scholar
• Beckenkamp LR, da Fontoura DMS, Korb VG, et al. Immortalization of mesenchymal stromal cells by TERT affects adenosine metabolism and impairs their immunosuppressive capacity. Stem Cell Rev Rep. 2020;16(4):776–791.
   PubMed Web of Science ®Google Scholar
• Simonsen JL, Rosada C, Serakinci N, et al. Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol. 2002;20(6):592–596.
   PubMed Web of Science ®Google Scholar
• Lee MK, Hande MP, Sabapathy K. Ectopic mTERT expression in mouse embryonic stem cells does not affect differentiation but confers resistance to differentiation- and stress-induced p53-dependent apoptosis. J Cell Sci. 2005;118:819–829.
   PubMed Web of Science ®Google Scholar
• Siska EK, Weisman I, Romano J, et al. Generation of an immortalized mesenchymal stem cell line producing a secreted biosensor protein for glucose monitoring. PLoS One. 2017;12(9):e0185498.
   PubMed Web of Science ®Google Scholar